Live Quote · NASDAQRAPTHealthcare· Biotechnology

RAPT Therapeutics, Inc.

$58.01 0.00%(+$0.00)
TickerSpark Score
57/100
Mixed
60
Valuation
20
Profitability
20
Growth
84
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RAPT research report →

52-Week Range100% of range
Low
$5.67
Current
$58.01
High
$58.02
Company Overviewwww.rapt.com

About the company

RAPT Therapeutics, Inc. is a clinical-stage biopharmaceutical firm specializing in immunology. The company is dedicated to discovering, developing, and commercializing innovative oral small molecule therapies.

CEO
Brian Russell Wong
IPO
2019
Employees
67
HQ
South San Francisco, CA, US

Price Chart

+547.43% · this period
$58.01$31.99$5.98Mar 06Sep 05Mar 06
Valuation
Market Cap
$959.26M
P/E
-29.87
P/S
0.00
P/B
10.29
EV/EBITDA
-17.86
Div Yield
0.00%
Profitability
Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
-31.83%
ROIC
-37.63%
Growth & Income
Revenue
$0 · 0.00%
Net Income
$-129,865,000 · -11.19%
EPS
$-25.49 · -4.58%
Op Income
$-136,101,000
FCF YoY
15.03%
Performance & Tape
52W High
$58.02
52W Low
$5.67
50D MA
$49.05
200D MA
$26.91
Beta
0.44
Avg Volume
2.34M

Get TickerSpark's AI analysis on RAPT

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Mar 3, 26Lyons-Williams Loriother4,956
Mar 3, 26Lyons-Williams Lorisell2,813
Mar 3, 26Lyons-Williams Lorisell1,063
Mar 3, 26Lyons-Williams Lorisell1,618
Mar 3, 26Lyons-Williams Lorisell4,561
Mar 3, 26Lyons-Williams Lorisell32,229
Mar 3, 26GRAY MARY ANNother4,956
Mar 3, 26GRAY MARY ANNsell2,813
Mar 3, 26GRAY MARY ANNsell498
Mar 3, 26GRAY MARY ANNsell938
Coverage · RAPT

Our RAPT coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on RAPT yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate RAPT report →
Internal Compare

Similar companies

Peers in the same neighborhood.